Delivery Order SPE2DB22D3501-SPE2DB25FXJ03
- Not listed
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens with a ceiling value of $3,072.24. The contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 8, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,128.30 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens. This is a firm fixed-price delivery order with a completion date of August 21, 2025, issued under a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with a contract value of $1,525.20. The order was competitively awarded without set-aside designation and is scheduled for completion by May 21, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,558.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $14,645.91 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on September 9, 2025, with completion targeted for September 10, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $18,697.47 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on June 27, 2025, with a completion date of June 30, 2025. This competitive award uses firm fixed pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,537.40 on June 2, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $29,010.80 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens on March 18, 2025, with completion targeted for March 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,682.27 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on September 5, 2025, with completion targeted for September 8, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime IDC running through December 2026. The product will be performed at the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXJ03Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens valued at $29,331.66 with a firm fixed price structure. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical supply vehicle that extends through December 2026, enabling the company to provide an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen has established itself as a critical federal medical procurement vendor, regularly fulfilling diverse pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio demonstrates capability in supplying a comprehensive range of medications spanning multiple therapeutic domains, from specialty drugs and brand-name pharmaceuticals to generic medications, vaccines, and medical devices. This particular award for Zepbound reflects AmerisourceBergen's ongoing role in supplying pharmaceutical products to support military medical readiness and healthcare delivery across the Department of Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 9/15/25 |